UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection

Clinical infectious diseases, 2011-02, Vol.52 (4), p.532-539

2011

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Outcome of Progressive Multifocal Leukoencephalopathy over 20 Years of the Swiss HIV Cohort Study

Clinical infectious diseases, 2009-05, Vol.48 (10), p.1459-1466

2009

Link zum Volltext

Verfügbarkeit prüfen

Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

Clinical infectious diseases, 2011-12, Vol.53 (11), p.1130-1139

2011

Link zum Volltext

Verfügbarkeit prüfen

Immune Reconstitution in HIV-Infected Patients

Clinical infectious diseases, 2004-04, Vol.38 (8), p.1159-1166

2004

Link zum Volltext

Verfügbarkeit prüfen

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/μL in HIV Type 1-Infected Individuals Receiving Potent Antiretroviral Therapy

Clinical infectious diseases, 2005-08, Vol.41 (3), p.361-372

2005

Link zum Volltext

Verfügbarkeit prüfen

Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

Clinical infectious diseases, 2014-01, Vol.58 (2), p.285-294

2014

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Risk Factors for Chronic Elevation of Alanine Aminotransferase Levels in HIV-Infected Persons without Hepatitis B or C Virus Co-Infection

Clinical infectious diseases, 2010-02, Vol.50 (4), p.502-511

2010

Link zum Volltext

Verfügbarkeit prüfen

The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/μL in the Post—Combination Antiretroviral Therapy Era

Clinical infectious diseases, 2013-10, Vol.57 (7), p.1038-1047

2013

Link zum Volltext

Verfügbarkeit prüfen

Is It Safe to Discontinue Primary Pneumocystis jiroveci Pneumonia Prophylaxis in Patients with Virologically Suppressed HIV Infection and a CD4 Cell Count <200 Cells/μL?

Clinical infectious diseases, 2010-09, Vol.51 (5), p.611-619

The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE)

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir

Clinical infectious diseases, 2014-11, Vol.59 (10), p.1420-1428

2014

Link zum Volltext

Verfügbarkeit prüfen

Incidence of HIV-1 Drug Resistance Among Antiretroviral Treatment-Naive Individuals Starting Modern Therapy Combinations

Clinical infectious diseases, 2012-01, Vol.54 (1), p.131-140

2012

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Trends of HIV Type 1 Drug Resistance Prevalence among Antiretroviral Treatment–Experienced Patients in Switzerland

Clinical infectious diseases, 2009-04, Vol.48 (7), p.979-987

2009

Link zum Volltext

Verfügbarkeit prüfen

HLA-Bw4 Homozygosity Is Associated with an Impaired CD4 T Cell Recovery after Initiation of Antiretroviral Therapy

Clinical infectious diseases, 2008-06, Vol.46 (12), p.1921-1925

2008

Link zum Volltext

Verfügbarkeit prüfen

CD4+ T Cell Count Recovery in HIV Type 1–Infected Patients Is Independent of Class of Antiretroviral Therapy

Clinical infectious diseases, 2008-10, Vol.47 (8), p.1093-1101

2008

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated with the Emergence of K65R in Patients with HIV-1 Infection Treated with Combination Antiretroviral Therapy Containing Tenofovir

Clinical infectious diseases, 2008-04, Vol.46 (8), p.1299-1309

2008

Link zum Volltext

Verfügbarkeit prüfen

Intranasal Influenza Vaccine in a Working Population

Clinical infectious diseases, 2004-04, Vol.38 (7), p.974-980

2004

Link zum Volltext

Verfügbarkeit prüfen

Increase in Sexual Risk Behavior Associated with Immunologic Response to Highly Active Antiretroviral Therapy among HIV-Infected Injection Drug Users

Clinical infectious diseases, 2004-04, Vol.38 (8), p.1167-1174

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals

Zeitschrift / SerieClinical Infectious Diseases

ThemaViral Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(17)
Human Viral Diseases
(17)
Infectious Diseases
(17)
Medical Sciences
(17)
Microbiology
(17)
Immunology
(16)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(15)
Hiv
(14)
Humans
(14)
Adult
(13)
Hiv/aids
(13)
Immunodeficiencies
(13)
Immunodeficiencies. Immunoglobulinopathies
(13)
Immunopathology
(13)
Male
(13)
Antiretrovirals
(12)
Female
(12)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford Journals Current Collection
(17)
Oxford Journals 2020 Medicine
(17)
JSTOR Archive Collection A-Z Listing
(17)
Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(17)
Journals@Ovid Ovid Full Text
(17)
Single Journals
(17)
MEDLINE
(14)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection

Incidence and Outcome of Progressive Multifocal Leukoencephalopathy over 20 Years of the Swiss HIV Cohort Study

Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

Immune Reconstitution in HIV-Infected Patients

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/μL in HIV Type 1-Infected Individuals Receiving Potent Antiretroviral Therapy

Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

Incidence and Risk Factors for Chronic Elevation of Alanine Aminotransferase Levels in HIV-Infected Persons without Hepatitis B or C Virus Co-Infection

The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/μL in the Post—Combination Antiretroviral Therapy Era

Is It Safe to Discontinue Primary Pneumocystis jiroveci Pneumonia Prophylaxis in Patients with Virologically Suppressed HIV Infection and a CD4 Cell Count <200 Cells/μL?

Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir

Incidence of HIV-1 Drug Resistance Among Antiretroviral Treatment-Naive Individuals Starting Modern Therapy Combinations

Long-Term Trends of HIV Type 1 Drug Resistance Prevalence among Antiretroviral Treatment–Experienced Patients in Switzerland

HLA-Bw4 Homozygosity Is Associated with an Impaired CD4 T Cell Recovery after Initiation of Antiretroviral Therapy

CD4+ T Cell Count Recovery in HIV Type 1–Infected Patients Is Independent of Class of Antiretroviral Therapy

Factors Associated with the Emergence of K65R in Patients with HIV-1 Infection Treated with Combination Antiretroviral Therapy Containing Tenofovir

Intranasal Influenza Vaccine in a Working Population

Increase in Sexual Risk Behavior Associated with Immunologic Response to Highly Active Antiretroviral Therapy among HIV-Infected Injection Drug Users

Aktive Filter

Suchergebnisse filtern